These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23808822)

  • 1. Fibroblast growth factor receptor 1 gene amplification in pancreatic ductal adenocarcinoma.
    Lehnen NC; von Mässenhausen A; Kalthoff H; Zhou H; Glowka T; Schütte U; Höller T; Riesner K; Boehm D; Merkelbach-Bruse S; Kirfel J; Perner S; Gütgemann I
    Histopathology; 2013 Aug; 63(2):157-66. PubMed ID: 23808822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 1 gene amplification in gastric adenocarcinoma.
    Schäfer MH; Lingohr P; Sträßer A; Lehnen NC; Braun M; Perner S; Höller T; Kristiansen G; Kalff JC; Gütgemann I
    Hum Pathol; 2015 Oct; 46(10):1488-95. PubMed ID: 26239623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers.
    Bae JM; Wen X; Kim TS; Kwak Y; Cho NY; Lee HS; Kang GH
    Cancer Res Treat; 2020 Jan; 52(1):74-84. PubMed ID: 31096734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
    Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
    Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays.
    Tsiambas E; Karameris A; Lazaris AC; Talieri M; Triantafillidis JK; Cheracakis P; Manaios L; Gerontopoulos K; Patsouris E; Lygidakis NJ
    Hepatogastroenterology; 2006; 53(69):452-7. PubMed ID: 16795991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
    Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues.
    Mohelnikova-Duchonova B; Brynychova V; Oliverius M; Honsova E; Kala Z; Muckova K; Soucek P
    Pancreas; 2013 May; 42(4):707-16. PubMed ID: 23462326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell Cancers.
    Göke F; Franzen A; Hinz TK; Marek LA; Yoon P; Sharma R; Bode M; von Maessenhausen A; Lankat-Buttgereit B; Göke A; Golletz C; Kirsten R; Boehm D; Vogel W; Kleczko EK; Eagles JR; Hirsch FR; Van Bremen T; Bootz F; Schroeck A; Kim J; Tan AC; Jimeno A; Heasley LE; Perner S
    Clin Cancer Res; 2015 Oct; 21(19):4356-64. PubMed ID: 26015511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H; Ebi H; Kitai H; Nanjo S; Kita K; Huynh TG; Ooi A; Faber AC; Mino-Kenudson M; Yano S
    Oncogene; 2016 Jul; 35(27):3587-97. PubMed ID: 26549034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor receptor 1 as a putative therapy target in colorectal cancer.
    Göke F; Göke A; von Mässenhausen A; Franzen A; Sharma R; Kirsten R; Böhm D; Kristiansen G; Stenzinger A; Wynes M; Hirsch FR; Weichert W; Heasley L; Buettner R; Perner S
    Digestion; 2013; 88(3):172-81. PubMed ID: 24135816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.
    Kim HR; Kim DJ; Kang DR; Lee JG; Lim SM; Lee CY; Rha SY; Bae MK; Lee YJ; Kim SH; Ha SJ; Soo RA; Chung KY; Kim JH; Lee JH; Shim HS; Cho BC
    J Clin Oncol; 2013 Feb; 31(6):731-7. PubMed ID: 23182986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z; Meng F; Li S; Zhang P
    Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR1 Amplification Is Often Homogeneous and Strongly Linked to the Squamous Cell Carcinoma Subtype in Esophageal Carcinoma.
    von Loga K; Kohlhaussen J; Burkhardt L; Simon R; Steurer S; Burdak-Rothkamm S; Jacobsen F; Sauter G; Krech T
    PLoS One; 2015; 10(11):e0141867. PubMed ID: 26555375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.
    Göke F; Franzen A; Menon R; Goltz D; Kirsten R; Boehm D; Vogel W; Göke A; Scheble V; Ellinger J; Gerigk U; Fend F; Wagner P; Schroeck A; Perner S
    Chest; 2012 Oct; 142(4):1020-1026. PubMed ID: 22499828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequencies and prognostic role of KRAS and BRAF mutations in patients with localized pancreatic and ampullary adenocarcinomas.
    Schultz NA; Roslind A; Christensen IJ; Horn T; Høgdall E; Pedersen LN; Kruhøffer M; Burcharth F; Wøjdemann M; Johansen JS
    Pancreas; 2012 Jul; 41(5):759-66. PubMed ID: 22699145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.